Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Imaflex Inc V.IFX

Alternate Symbol(s):  IFLXF

Imaflex Inc. is focused on the development and manufacturing of solutions for the flexible packaging and agriculture industries. The Company’s products consist primarily of polyethylene (plastic) film and bags, including metalized plastic film, for the industrial, agricultural and consumer markets. Its polyethylene films are mainly sold to printers known as converters, who process the film into a finished product to meet their end-customer needs. Additionally, its films are sold directly to customers to protect and market their own products or bought by distributors for re-sale. Its agricultural films are finished products, predominantly sold directly by the Company to growers. Its portfolio includes common mulch, compostable and fumigant barrier films, as well as metalized crop protection films that add pest/weed control and/or accelerated growth benefits beyond those provided by its common mulch films. It has manufacturing facilities in Canada and the United States.


TSXV:IFX - Post by User

Comment by Ciaoon Oct 17, 2024 5:35pm
209 Views
Post# 36270685

RE:Small Cap Discovery Interview

RE:Small Cap Discovery InterviewEPA decision on Advaseal could be 6 months, could be a year. They will partner for Advaseal. Pre-plant use of this film would be in the $B of dollars in U.S. Margins on Advaseal would have 30 plus EBITDA margins. 

Talk of a NCIB or dividend was encouraging.
<< Previous
Bullboard Posts
Next >>